Cinacalcet Administration by Gastrostomy Tube in a Child Receiving Peritoneal Dialysis

Kristen R. Nichols, Chad A. Knoderer, Bethanne Johnston, Amy C. Wilson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    A 2-year-old male with chronic kidney disease with secondary hyperparathyroidism developed hypercalcemia while receiving calcitriol, without achieving a serum parathyroid hormone concentration within the goal range. Cinacalcet 15 mg (1.2 mg/kg), crushed and administered via gastrostomy tube, was added to the patient’s therapy. This therapy was effective in achieving targeted laboratory parameters in our patient despite instructions in the prescribing information that cinacalcet should always be taken whole.

    Original languageAmerican English
    JournalJournal of Pediatric Pharmacology and Therapy
    Volume19
    DOIs
    StatePublished - Jan 1 2014

    Keywords

    • chronic kidney disease
    • cinacalcet
    • hypercalcemia
    • secondary hyperparathyroidism

    Disciplines

    • Pediatrics
    • Pharmaceutics and Drug Design
    • Pharmacy and Pharmaceutical Sciences

    Cite this